Notch signaling pathway
The Notch signaling pathway is a highly conserved cell signaling system present in most multicellular organisms. Notch is present in all metazoans, and mammals possess four different notch receptors, referred to as NOTCH1, NOTCH2, NOTCH3, and NOTCH4. The notch receptor is a single-pass transmembrane receptor protein. It is a hetero-oligomer composed of a large extracellular portion, which associates in a calcium-dependent, non-covalent interaction with a smaller piece of the notch protein composed of a short extracellular region, a single transmembrane-pass, and a small intracellular region. Notch signaling promotes proliferative signaling during neurogenesis, and its activity is inhibited by Numb to promote neural differentiation.
- 1 Discovery
- 2 Mechanism of action
- 3 Function
- 4 Pathway
- 5 Notch signaling in embryogenesis
- 6 Notch signaling in central nervous system development and function
- 7 Notch signaling in cardiovascular development
- 8 Notch signaling in endocrine development
- 9 Notch signaling in cancer
- 10 External links
- 11 References
In 1914, John S. Dexter noticed the appearance of a notch in the wings of the fruit fly Drosophila melanogaster. The alleles of the gene were identified in 1917 by Thomas Hunt Morgan. Its molecular analysis and sequencing was independently undertaken in the 1980s by Spyros Artavanis-Tsakonas and Michael W. Young. Alleles of the two C. elegans Notch genes were identified based on developmental phenotypes: lin-12 and glp-1. The cloning and partial sequence of lin-12 was reported at the same time as Drosophila Notch by Iva Greenwald.
Mechanism of action
The Notch protein spans the cell membrane, with part of it inside and part outside. Ligand proteins binding to the extracellular domain induce proteolytic cleavage and release of the intracellular domain, which enters the cell nucleus to modify gene expression.
The cleavage model was first proposed in 1993 based on work done with Drosophila Notch and C. elegans lin-12, informed by the first oncogenic mutation affecting a human Notch gene. Compelling evidence for this model was provided in 1998 by in vivo analysis in Drosophila by Gary Struhl and in cell culture by Raphael Kopan. Although this model was initially disputed, the evidence in favor of the model was irrefutable by 2001.
The receptor is normally triggered via direct cell-to-cell contact, in which the transmembrane proteins of the cells in direct contact form the ligands that bind the notch receptor. The Notch binding allows groups of cells to organize themselves, such that, if one cell expresses a given trait, this may be switched off in neighbouring cells by the intercellular notch signal. In this way, groups of cells influence one another to make large structures. Thus, lateral inhibition mechanisms are key to Notch signaling. lin-12 and Notch mediate binary cell fate decisions, and lateral inhibition involves feedback mechanisms to amplify initial differences.
The Notch cascade consists of Notch and Notch ligands, as well as intracellular proteins transmitting the notch signal to the cell's nucleus. The Notch/Lin-12/Glp-1 receptor family was found to be involved in the specification of cell fates during development in Drosophila and C. elegans.
The notch signaling pathway is important for cell-cell communication, which involves gene regulation mechanisms that control multiple cell differentiation processes during embryonic and adult life. Notch signaling also has a role in the following processes:
- neuronal function and development
- stabilization of arterial endothelial fate and angiogenesis
- regulation of crucial cell communication events between endocardium and myocardium during both the formation of the valve primordial and ventricular development and differentiation
- cardiac valve homeostasis, as well as implications in other human disorders involving the cardiovascular system
- timely cell lineage specification of both endocrine and exocrine pancreas
- influencing of binary fate decisions of cells that must choose between the secretory and absorptive lineages in the gut
- expansion of the hematopoietic stem cell compartment during bone development and participation in commitment to the osteoblastic lineage, suggesting a potential therapeutic role for notch in bone regeneration and osteoporosis
- expansion of the hemogenic endothelial cells along with signaling axis involving Hedgehog signaling and Scl 
- T cell lineage commitment from common lymphoid precursor 
- regulation of cell-fate decision in mammary glands at several distinct development stages
- possibly some non-nuclear mechanisms, such as control of the actin cytoskeleton through the tyrosine kinase Abl
Notch signaling is dysregulated in many cancers, and faulty notch signaling is implicated in many diseases including T-ALL (T-cell acute lymphoblastic leukemia), CADASIL (Cerebral Autosomal-Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy), MS (Multiple Sclerosis), Tetralogy of Fallot, Alagille syndrome, and many other disease states.
Inhibition of notch signaling has been shown to have anti-proliferative effects on T-cell acute lymphoblastic leukemia in cultured cells and in a mouse model. It has also been found that Rex1 has inhibitory effects on the expression of notch in mesenchymal stem cells, preventing differentiation.
Maturation of the notch receptor involves cleavage at the prospective extracellular side during intracellular trafficking in the Golgi complex. This results in a bipartite protein, composed of a large extracellular domain linked to the smaller transmembrane and intracellular domain. Binding of ligand promotes two proteolytic processing events; as a result of proteolysis, the intracellular domain is liberated and can enter the nucleus to engage other DNA-binding proteins and regulate gene expression.
Notch and most of its ligands are transmembrane proteins, so the cells expressing the ligands typically must be adjacent to the notch expressing cell for signaling to occur. The notch ligands are also single-pass transmembrane proteins and are members of the DSL (Delta/Serrate/LAG-2) family of proteins. In Drosophila melanogaster (the fruit fly), there are two ligands named Delta and Serrate. In mammals, the corresponding names are Delta-like and Jagged. In mammals there are multiple Delta-like and Jagged ligands, as well as possibly a variety of other ligands, such as F3/contactin.
In the nematode C. elegans, two genes encode homologous proteins, glp-1 and lin-12. There has been at least one report that suggests that some cells can send out processes that allow signaling to occur between cells that are as much as four or five cell diameters apart.
Notch 1, for example, has 36 of these repeats. Each EGF-like repeat is composed of approximately 40 amino acids, and its structure is defined largely by six conserved cysteine residues that form three conserved disulfide bonds. Each EGF-like repeat can be modified by O-linked glycans at specific sites. An O-glucose sugar may be added between the first and second conserved cysteines, and an O-fucose may be added between the second and third conserved cysteines. These sugars are added by an as-yet-unidentified O-glucosyltransferase (except for Rumi), and GDP-fucose Protein O-fucosyltransferase 1 (POFUT1), respectively. The addition of O-fucose by POFUT1 is absolutely necessary for notch function, and, without the enzyme to add O-fucose, all notch proteins fail to function properly. As yet, the manner by which the glycosylation of notch affects function is not completely understood.
The O-glucose on notch can be further elongated to a trisaccharide with the addition of two xylose sugars by xylosyltransferases, and the O-fucose can be elongated to a tetrasaccharide by the ordered addition of an N-acetylglucosamine (GlcNAc) sugar by an N-Acetylglucosaminyltransferase called Fringe, the addition of a galactose by a galactosyltransferase, and the addition of a sialic acid by a sialyltransferase.
To add another level of complexity, in mammals there are three Fringe GlcNAc-transferases, named lunatic fringe, manic fringe, and radical fringe. These enzymes are responsible for something called a "fringe effect" on notch signaling. If Fringe adds a GlcNAc to the O-fucose sugar then the subsequent addition of a galactose and sialic acid will occur. In the presence of this tetrasaccharide, notch signals strongly when it interacts with the Delta ligand, but has markedly inhibited signaling when interacting with the Jagged ligand. The means by which this addition of sugar inhibits signaling through one ligand, and potentiates signaling through another is not clearly understood.
Once the notch extracellular domain interacts with a ligand, an ADAM-family metalloprotease called ADAM10, cleaves the notch protein just outside the membrane. This releases the extracellular portion of notch, which continues to interact with the ligand. The ligand plus the notch extracellular domain is then endocytosed by the ligand-expressing cell. There may be signaling effects in the ligand-expressing cell after endocytosis; this part of notch signaling is a topic of active research. After this first cleavage, an enzyme called γ-secretase (which is implicated in Alzheimer's disease) cleaves the remaining part of the notch protein just inside the inner leaflet of the cell membrane of the notch-expressing cell. This releases the intracellular domain of the notch protein, which then moves to the nucleus, where it can regulate gene expression by activating the transcription factor CSL. It was originally thought that these CSL proteins suppressed Notch target transcription. However, further research showed that, when the intracellular domain binds to the complex, it switches from a repressor to an activator of transcription. Other proteins also participate in the intracellular portion of the notch signaling cascade.
Notch signaling in embryogenesis
The Notch signaling pathway plays an important role in cell-cell communication, and further regulates embryonic development. Early studies in C. elegans indicate that Notch signaling has a major role in the induction of mesoderm and cell fate determination.
Notch signaling in embryo polarity
Notch signaling is required in the regulation of polarity. For example, mutation experiments have shown that loss of Notch signaling causes abnormal anterior-posterior polarity in somites. Also, Notch signaling is required during left-right asymmetry determination in vertebrates.
Notch signaling in somitogenesis
Notch signaling is central to somitogenesis. In 1995, Notch1 was shown to be important for coordinating the segmentation of somites in mice. Further studies identified the role of Notch signaling in the segmentation clock. These studies hypothesized that the primary function of Notch signaling does not act on an individual cell, but coordinates cell clocks and keep them synchronized. This hypothesis explained the role of Notch signaling in the development of segmentation and has been supported by experiments in mice and zebrafish. Experiments with Delta1 mutant mice that show abnormal somitogenesis with loss of anterior/posterior polarity suggest that Notch signaling is also necessary for the maintenance of somite borders.
Notch signaling in central nervous system development and function
Early findings on Notch signaling in Central Nervous System (CNS) development were performed mainly in Drosophila with mutagenesis experiments. For example, the finding that an embryonic lethal phenotype in Drosophila was associated with Notch dysfunction indicated that Notch mutations can lead to the failure of neural and Epidermal cell segregation in early Drosophila embryos. In the past decade, advances in mutation and knockout techniques allowed research on the Notch signaling pathway in mammalian models, especially rodents.
The Notch signaling pathway was found to be critical mainly for neural progenitor cell (NPC) maintenance and self-renewal. In recent years, other functions of the Notch pathway have also been found, including glial cell specification, neurites development, as well as learning and memory.
Notch signaling in neuron cell differentiation
The Notch pathway is essential for maintaining NPCs in the developing brain. Activation of the pathway is sufficient to maintain NPCs in a proliferating state, whereas loss-of-function mutations in the critical components of the pathway cause precocious neuronal differentiation and NPC depletion. Modulators of the Notch signal, e.g., the Numb protein are able to antagonize Notch effects, resulting in the halting of cell cycle and differentiation of NPCs. In this way, Notch signaling controls NPC self-renewal as well as cell fate specification.
A non-canonical branch of the Notch signaling pathway that involves the phosphorylation of STAT3 on the serine residue at amino acid position 727 and subsequent Hes3 expression increase (STAT3-Ser/Hes3 Signaling Axis) has been shown to regulate the number of NPCs in culture and in the adult rodent brain.
In adult rodents and in cell culture, Notch3 promotes neuronal differentiation, having a role opposite to Notch1/2. This indicates that individual Notch receptors can have divergent functions, depending on cellular context.
Notch signaling in neurite development
In vitro studies show that Notch can influence neurite development. In vivo, deletion of the Notch signaling modulator, Numb, disrupts neuronal maturation in the developing cerebellum, whereas deletion of Numb disrupts axonal arborization in sensory ganglia. Although the mechanism underlying this phenomenon is not clear, together these findings suggest Notch signaling might be crucial in neuronal maturation.
Notch signaling in gliogenesis
In gliogenesis, Notch appears to have an instructive role that can directly promote the differentiation of many glial cell subtypes. For example, activation of Notch signaling in the retina favors the generation of Muller glia cells at the expense of neurons, whereas reduced Notch signaling induces production of ganglion cells, causing a reduction in the number of Muller glia.
Notch signaling in adult brain function
In addition to developmental functions, Notch proteins and ligands are expressed in cells of the adult nervous system, suggesting a role in CNS plasticity throughout life. Adult mice heterozygous for mutations in either Notch1 or Cbf1 have deficits in spatial learning and memory. Similar results are seen in experiments with presenilins1 and 2, which mediate the Notch intramembranous cleavage. To be specific, conditional deletion of presenilins at 3 weeks after birth in excitatory neurons causes learning and memory deficits, neuronal dysfunction, and gradual neurodegeneration. Several gamma secretase inhibitors that underwent human clinical trials in Alzheimer's disease and MCI patients resulted in statistically significant worsening of cognition relative to controls, which is thought to be due to its incidental effect on Notch signalling.
Notch signaling in cardiovascular development
The Notch signaling pathway is a critical component of cardiovascular formation and morphogenesis in both development and disease. It is required for the selection of endothelial tip and stalk cells during sprouting angiogenesis.
Notch signaling in cardiac development
1. Notch signaling in atrioventricular (AV) canal development
- AV boundary formation
- Notch signaling can regulate the atrioventricular boundary formation between the AV canal and the chamber myocardium.
Studies have revealed that both loss- and gain-of-function of the Notch pathway results in defects in AV canal development. In addition, the Notch target genes HEY1 and HEY2 are involved in restricting the expression of two critical developmental regulator proteins, BMP2 and Tbx2, to the AV canal.
- AV epithelial-mesenchymal transition (EMT)
- Notch signaling is also important for the process of AV EMT, which is required for AV canal maturation. After the AV canal boundary formation, a subset of endocardial cells lining the AV canal are activated by signals emanating from the myocardium and by interendocardial signaling pathways to undergo EMT. Notch1 deficiency results in defective induction of EMT. Very few migrating cells are seen and these lack mesenchymal morphology. Notch may regulate this process by activating matrix metalloproteinase2 (MMP2) expression, or by inhibiting vascular endothelial (VE)-cadherin expression in the AV canal endocardium while suppressing the VEGF pathway via VEGFR2. In RBPJk/CBF1-targeted mutants, the heart valve development is severely disrupted, presumably because of defective endocardial maturation and signaling.
2. Notch signaling in ventricular development
- Some studies in Xenopus and in mouse embryonic stem cells indicate that cardiomyogenic commitment and differentiation require Notch signaling inhibition. Active Notch signaling is required in the ventricular endocardium for proper trabeculae development subsequent to myocardial specification by regulating BMP10, NRG1, and EphrinB2 expression.
- The downstream effector of Notch signaling, HEY2, was also demonstrated to be important in regulating ventricular development by its expression in the interventricular septum and the endocardial cells of the cardiac cushions. Cardiomyocyte and smooth muscle cell-specific deletion of HEY2 results in impaired cardiac contractility, malformed right ventricle, and ventricular septal defects.
3. Notch signaling in ventricular outflow tract development
- During development of the aortic arch and the aortic arch arteries, the Notch receptors, ligands, and target genes display a unique expression pattern. When the Notch pathway was blocked, the induction of vascular smooth muscle cell marker expression failed to occur, suggesting that Notch is involved in the differentiation of cardiac neural crest cells into vascular cells during outflow tract development.
Notch signaling in angiogenesis
Activation of Notch takes place primarily in "connector" cells and cells that line patent stable blood vessels through direct interaction with the Notch ligand, Delta-like ligand 4 (Dll4), which is expressed in the endothelial tip cells. VEGF signaling, which is an important factor for migration and proliferation of endothelial cells, can be downregulated in cells with activated Notch signaling by lowering the levels of Vegf receptor transcript. Zebrafish embryos lacking Notch signaling exhibit ectopic and persistent expression of the zebrafish ortholog of VEGF3, flt4, within all endothelial cells, while Notch activation completely represses its expression.
Notch signaling may be used to control the sprouting pattern of blood vessels during angiogenesis. When cells within a patent vessel are exposed to VEGF signaling, only a restricted number of them initiate the angiogenic process. Vegf is able to induce DLL4 expression. In turn, DLL4 expressing cells down-regulate Vegf receptors in neighboring cells through activation of Notch, thereby preventing their migration into the developing sprout. Likewise, during the sprouting process itself, the migratory behavior of connector cells must be limited to retain a patent connection to the original blood vessel.
Notch signaling in endocrine development
During development, definitive endoderm and ectoderm differentiates into several gastrointestinal epithelial lineages, including endocrine cells. Many studies have indicated that Notch signaling has a major role in endocrine development.
Notch signaling in pancreatic development
The formation of the pancreas from endoderm begins in early development. The expression of elements of the Notch signaling pathway have been found in the developing pancreas, suggesting that Notch signaling is important in pancreatic development. Evidence suggests Notch signaling regulates the progressive recruitment of endocrine cell types from a common precursor, acting through two possible mechanisms. One is the "lateral inhibition", which specifies some cells for a primary fate but others for a secondary fate among cells that have the potential to adopt the same fate. Lateral inhibition is required for many types of cell fate determination. Here, it could explain the dispersed distribution of endocrine cells within pancreatic epithelium. A second mechanism is "suppressive maintenance", which explains the role of Notch signaling in pancreas differentiation. Fibroblast growth factor10 is thought to be important in this activity, but the details are unclear.
Notch signaling and intestinal development
The role of Notch signaling in the regulation of gut development has been indicated in several reports. Mutations in elements of the Notch signaling pathway affect the earliest intestinal cell fate decisions during zebrafish development. Transcriptional analysis and gain of function experiments revealed that Notch signaling targets Hes1 in the intestine and regulates a binary cell fate decision between adsorptive and secretory cell fates.
Notch signaling and bone development
Early in vitro studies have found the Notch signaling pathway functions as down-regulator in osteoclastogenesis and osteoblastogenesis. Notch1 is expressed in the mesenchymal condensation area and subsequently in the hypertrophic chondrocytes during chondrogenesis. Overexpression of Notch signaling inhibits bone morphogenetic protein2-induced osteoblast differentiation. Overall, Notch signaling has a major role in the commitment of mesenchymal cells to the osteoblastic lineage and provides a possible therapeutic approach to bone regeneration.
Notch signaling in cancer
The involvement of Notch signalling in many cancers has led to investigation of notch inhibitors (especially gamma-secretase inhibitors) as cancer treatments. As of 2013[update] at least 7 notch inhibitors were in clinical trials. MK-0752 has given promising results in an early clinical trial for breast cancer.
- Diagram: notch signaling pathway in Homo sapiens
- Diagram: Notch signaling in Drosophila
- Netpath - A curated resource of signal transduction pathways in humans
- Notch Receptors at the US National Library of Medicine Medical Subject Headings (MeSH)
- Artavanis-Tsakonas, Spyros et al. (1999-04-30). "Notch Signaling: Cell Fate Control and Signal Integration in Development (Review)". Science 284 (5415): 770–776. Bibcode:1999Sci...284..770A. doi:10.1126/science.284.5415.770. PMID 10221902.
- Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, Cumano A, Roux P, Black RA, Israël A (February 2000). "A novel proteolytic cleavage involved in notch signaling: the role of the disintegrin-metalloprotease TACE". Mol. Cell 5 (2): 207–16. doi:10.1016/S1097-2765(00)80417-7. PMID 10882063.
- Thomas Hunt Morgan (1917). "The theory of the gene". The American Naturalist 51 (609): 513–544. doi:10.1086/279629.
- Morgan, Thomas (1928). The theory of the gene (revised ed.). Yale University Press. pp. 77–81. ISBN 0-8240-1384-0.
- Wharton KA, Johansen KM, Xu T, Artavanis-Tsakonas S (December 1985). "Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats". Cell 43 (3 Pt 2): 567–81. doi:10.1016/0092-8674(85)90229-6. PMID 3935325.
- Kidd S, Kelley MR, Young MW (September 1986). "Sequence of the notch locus of Drosophila melanogaster: relationship of the encoded protein to mammalian clotting and growth factors". Mol. Cell. Biol. 6 (9): 3094–108. PMC 367044. PMID 3097517.
- Greenwald, Iva S.; Sternberg, Paul W.; Horvitz, H. Robert (September 1983). "The lin-12 locus specifies cell fates in caenorhabditis elegans". Cell 34 (2): 435–444. doi:10.1016/0092-8674(83)90377-X. PMID 6616618. Retrieved 13 December 2014.
- Austin, Judithe; Kimble, Judith (20 November 1987). "glp-1 Is required in the germ line for regulation of the decision between mitosis and meiosis in C. elegans". Cell 51 (4): 589–599. doi:10.1016/0092-8674(87)90128-0. PMID 3677168. Retrieved 13 December 2014.
- Priess, James R.; Schnabel, Heinke; Schnabel, Ralf (20 November 1987). "The glp-1 locus and cellular interactions in early C. elegans embryos". Cell 51 (4): 601–611. doi:10.1016/0092-8674(87)90129-2. PMID 3677169. Retrieved 13 December 2014.
- Greenwald, Iva (December 1985). "lin-12, a nematode homeotic gene, is homologous to a set of mammalian proteins that includes epidermal growth factor". Cell 43 (3, Part 2): 583–590. doi:10.1016/0092-8674(85)90230-2. PMID 3000611. Retrieved 13 December 2014.
- Oswald F, Täuber B, Dobner T, Bourteele S, Kostezka U, Adler G, Liptay S, Schmid RM (November 2001). "p300 acts as a transcriptional coactivator for mammalian notch-1". Mol. Cell. Biol. 21 (22): 7761–74. doi:10.1128/MCB.21.22.7761-7774.2001. PMC 99946. PMID 11604511.
- Lieber, Toby; Kidd, Simon; Alcamo, Elizabeth; Corbin, Victoria; Young, Michael W. (Oct 1993). "Antineurogenic phenotypes induced by truncated Notch proteins indicate a role in signal transduction and may point to a novel function for Notch in nuclei". Genes & Development 7 (10): 1949–65. doi:10.1101/gad.7.10.1949. PMID 8406001. Retrieved 14 December 2014.
- Struhl, Gary; Fitzgerald, Kevin; Greenwald, Iva (30 July 1993). "Intrinsic activity of the Lin-12 and Notch intracellular domains in vivo". Cell 74 (2): 331–45. doi:10.1016/0092-8674(93)90424-O. PMID 8343960. Retrieved 14 December 2014.
- Ellisen, Leif W.; Bird, Jeffrey; West, Daniel C.; Soreng, A. Lee; Reynolds, Thomas C.; Smith, Stephen D.; Sklar, Jeffrey (23 August 1991). "TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms". Cell 66 (4): 649–61. doi:10.1016/0092-8674(91)90111-B. PMID 1831692. Retrieved 14 December 2014.
- Struhl, Gary; Adachi, Atsuko (15 May 1998). "Nuclear Access and Action of Notch In Vivo". Cell 93 (4): 649–60. doi:10.1016/S0092-8674(00)81193-9. PMID 9604939. Retrieved 14 December 2014.
- Schroeter, Eric H.; Kisslinger, Jeffrey A.; Kopan, Raphael (28 May 1998). "Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain". Nature 393 (6683): 382–6. doi:10.1038/30756. PMID 9620803. Retrieved 14 December 2014.
- Greenwald, Iva (1 July 2012). "Notch and the Awesome Power of Genetics". Genetics 191 (3): 655–69. doi:10.1534/genetics.112.141812. PMID 22785620. Retrieved 14 December 2014.
- Struhl, Gary; Greenwald, Iva (2 January 2001). "Presenilin-mediated transmembrane cleavage is required for Notch signal transduction in Drosophila". Proc Natl Acad Sci USA 98 (1): 229–34. doi:10.1073/pnas.98.1.229. PMC 14573. PMID 11134525.
- Artavanis-Tsakonas S, Matsuno K, Fortini ME (April 1995). "Notch signaling". Science 268 (5208): 225–32. Bibcode:1995Sci...268..225A. doi:10.1126/science.7716513. PMID 7716513.
- Singson A, Mercer KB, L'Hernault SW (April 1998). "The C. elegans spe-9 gene encodes a sperm transmembrane protein that contains EGF-like repeats and is required for fertilization". Cell 93 (1): 71–9. doi:10.1016/S0092-8674(00)81147-2. PMID 9546393.
- Nam, Yunsun; Sliz, Piotr; Song, Luyan; Aster, Jon C.; Blacklow, Stephen C. (10 March 2006). "Structural Basis for Cooperativity in Recruitment of MAML Coactivators to Notch Transcription Complexes". Cell 124 (5): 973–83. doi:10.1016/j.cell.2005.12.037. PMID 16530044. Retrieved 15 December 2014.
- Wilson, Jeffrey J.; Kovall, Rhett A. (10 March 2006). "Crystal Structure of the CSL-Notch-Mastermind Ternary Complex Bound to DNA". Cell 124 (5): 985–96. doi:10.1016/j.cell.2006.01.035. PMID 16530045. Retrieved 15 December 2014.
- Gaiano N, Fishell G (2002). "The role of notch in promoting glial and neural stem cell fates". Annu. Rev. Neurosci. 25 (1): 471–90. doi:10.1146/annurev.neuro.25.030702.130823. PMID 12052917.
- Bolós V, Grego-Bessa J, de la Pompa JL (May 2007). "Notch signaling in development and cancer". Endocr. Rev. 28 (3): 339–63. doi:10.1210/er.2006-0046. PMID 17409286.
- Aguirre A, Rubio ME, Gallo V (2010). "Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal". Nature 467 (7313): 323–327. Bibcode:2010Natur.467..323A. doi:10.1038/nature09347. PMC 2941915. PMID 20844536.
- Hitoshi S et al. (April 2002). "Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells". Genes Dev. 16 (7): 846–858. doi:10.1101/gad.975202. PMC 186324. PMID 11937492.
- Liu ZJ, Shirakawa T, Li Y, Soma A, Oka M, Dotto GP, Fairman RM, Velazquez OC, Herlyn M (January 2003). "Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis". Mol. Cell. Biol. 23 (1): 14–25. doi:10.1128/MCB.23.1.14-25.2003. PMC 140667. PMID 12482957.
- Grego-Bessa J, Luna-Zurita L, del Monte G, Bolós V, Melgar P, Arandilla A, Garratt AN, Zang H, Mukouyama YS, Chen H, Shou W, Ballestar E, Esteller M, Rojas A, Pérez-Pomares JM, de la Pompa JL (March 2007). "Notch signaling is essential for ventricular chamber development". Dev. Cell 12 (3): 415–29. doi:10.1016/j.devcel.2006.12.011. PMC 2746361. PMID 17336907.
- The notch signaling pathway in cardiac development and tissue homeostasis
- Murtaugh LC, Stanger BZ, Kwan KM, Melton DA (December 2003). "Notch signaling controls multiple steps of pancreatic differentiation". Proc. Natl. Acad. Sci. U.S.A. 100 (25): 14920–5. Bibcode:2003PNAS..10014920M. doi:10.1073/pnas.2436557100. PMC 299853. PMID 14657333.
- Sander GR, Powell BC (April 2004). "Expression of notch receptors and ligands in the adult gut". J. Histochem. Cytochem. 52 (4): 509–16. doi:10.1177/002215540405200409. PMID 15034002.
- Nobta M, Tsukazaki T, Shibata Y, Xin C, Moriishi T, Sakano S, Shindo H, Yamaguchi A (April 2005). "Critical regulation of bone morphogenetic protein-induced osteoblastic differentiation by Delta1/Jagged1-activated notch1 signaling". J. Biol. Chem. 280 (16): 15842–8. doi:10.1074/jbc.M412891200. PMID 15695512.
- Kim PG, Albacker CE, Lu YF, Jang IH, Lim Y, Heffner GC, Arora N, Bowman TV, Lin MI, Lensch MW, De Los Angeles A, Zon LI, Loewer S, Daley GQ (January 2013). "Signaling axis involving Hedgehog, Notch, and Scl promotes the embryonic endothelial-to-hematopoietic transition". Proc Natl Acad Sci U S A 110 (2): E141–50. Bibcode:2013PNAS..110E.141K. doi:10.1073/pnas.1214361110. PMID 23236128.
- Laky K, Fowlkes BJ (April 2008). "Notch signaling in CD4 and CD8 T cell development.". Current opinion in immunology 20 (2): 197–202. doi:10.1016/j.coi.2008.03.004. PMC 2475578. PMID 18434124.
- Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS (2004). "Role of notch signaling in cell-fate determination of human mammary stem/progenitor cells". Breast Cancer Res. 6 (6): R605–15. doi:10.1186/bcr920. PMC 1064073. PMID 15535842.
- Lai EC (March 2004). "Notch signaling: control of cell communication and cell fate". Development 131 (5): 965–73. doi:10.1242/dev.01074. PMID 14973298.
- "The NOTCH pathway and Cancer". healthvalue.net. Retrieved 2009-03-08.
- Sharma VM, Draheim KM, Kelliher MA (April 2007). "The Notch1/c-Myc pathway in T cell leukemia". Cell Cycle 6 (8): 927–30. doi:10.4161/cc.6.8.4134. PMID 17404512.
- Moellering RE et al. (2009-11-12). "Direct inhibition of the NOTCH transcription factor complex". Nature 462 (7270): 182–188. Bibcode:2009Natur.462..182M. doi:10.1038/nature08543. PMC 2951323. PMID 19907488.
- Arora, Paramjit S.; Ansari, Aseem Z. (2009-11-12). "Chemical biology: A notch above other inhibitors". Nature 462 (7270): 171–173. Bibcode:2009Natur.462..171A. doi:10.1038/462171a. PMID 19907487.
- Bagley, Katherine (2009-11-11). "New drug target for cancer". The Scientist. Retrieved 2009-11-11.
- Bhandari, D. R.; Seo, K. W.; Roh, K. H.; Jung, J. W.; Kang, S. K.; Kang, K. S. (2010). Pera, Martin, ed. "REX-1 Expression and p38 MAPK Activation Status Can Determine Proliferation/Differentiation Fates in Human Mesenchymal Stem Cells". PLoS ONE 5 (5): e10493. doi:10.1371/journal.pone.0010493. PMC 2864743. PMID 20463961.
- Munro S, Freeman M (July 2000). "The notch signalling regulator fringe acts in the Golgi apparatus and requires the glycosyltransferase signature motif DXD". Curr. Biol. 10 (14): 813–20. doi:10.1016/S0960-9822(00)00578-9. PMID 10899003.
- Ma B, Simala-Grant JL, Taylor DE (December 2006). "Fucosylation in prokaryotes and eukaryotes". Glycobiology 16 (12): 158R–184R. doi:10.1093/glycob/cwl040. PMID 16973733.
- Shao L, Luo Y, Moloney DJ, Haltiwanger R (November 2002). "O-glycosylation of EGF repeats: identification and initial characterization of a UDP-glucose: protein O-glucosyltransferase". Glycobiology 12 (11): 763–70. doi:10.1093/glycob/cwf085. PMID 12460944.
- Lu L, Stanley P (2006). "Roles of O-fucose glycans in notch signaling revealed by mutant mice". Meth. Enzymol. 417: 127–36. doi:10.1016/S0076-6879(06)17010-X. PMID 17132502.
- Thomas GB, van Meyel DJ (February 2007). "The glycosyltransferase Fringe promotes Delta-Notch signaling between neurons and glia, and is required for subtype-specific glial gene expression". Development 134 (3): 591–600. doi:10.1242/dev.02754. PMID 17215308.
- LaVoie MJ, Selkoe DJ (September 2003). "The notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signaling fragments". J. Biol. Chem. 278 (36): 34427–37. doi:10.1074/jbc.M302659200. PMID 12826675.
- van Tetering G, van Diest P, Verlaan I, van der Wall E, Kopan R, Vooijs M (April 2010). "Metalloprotease ADAM10 is required for Notch1 site 2 cleavage". J Biol Chem 9 (258): 31018–27. doi:10.1074/jbc.M109.006775. PMID 19726682.
- Desbordes, Sabrina; Hernan Lopez-Schier (2005). "Drosophila Patterning: Delta-Notch Interactions". Encyclopedia of Life Sciences: 4. doi:10.1038/npg.els.0004194. Check date values in:
- Borggrefe T, Liefke R (January 2012). "Fine-tuning of the intracellular canonical Notch signaling pathway". Cell Cycle 11 (2): 264–76. doi:10.4161/cc.11.2.18995. PMID 22223095.
- Austin J., Kimble J. (Nov 1987). "glp-1 is required in the germ line for regulation of the decision between mitosis and meiosis in C. elegans. (1987)". Cell 51 (4): 589–599. doi:10.1016/0092-8674(87)90128-0. PMID 3677168.
- Feller J, Schneider A, Schuster-Gossler K, Gossler A. "Noncyclic Notch activity in the presomitic mesoderm demonstrates uncoupling of somite compartmentalization and boundary formation. (2008)". Genes Dev 22: 2166–2171. doi:10.1101/gad.480408.
- Levin M. "Left-right asymmetry in embryonic development:a comprehensive review. (2005)". Mech Dev 122 (1): 3–25. doi:10.1016/j.mod.2004.08.006.
- Conlon RA, Reaume AG, Rossant J (May 1995). "Notch1 is required for the coordinate segmentation of somites". Development 121 (5): 1533–45. PMID 7789282.
- Hrabe , de Angelis M, McIntyre JN, Gossler A (1997). "Maintenance of somite borders in mice requires the Delta homologue DII1". Nature 386 (6626): 717–721. Bibcode:1997Natur.386..717D. doi:10.1038/386717a0.
- van Eeden FJ, Granato M, Schach U et al. (December 1996). "Mutations affecting somite formation and patterning in the zebrafish, Danio rerio". Development 123: 153–64. PMID 9007237.
- Huppert SS, Ilagan MX, De Strooper B, Kopan R. "Analysis of Notch function in presomitic mesoderm suggests a gamma-secretase-independent role for presenilins in somite differentiation. (2005)". Dev Cell 8: 677–688. doi:10.1016/j.devcel.2005.02.019.
- Poulson DF (March 1937). "Chromosomal Deficiencies and the Embryonic Development of Drosophila Melanogaster". Proc. Natl. Acad. Sci. U.S.A. 23 (3): 133–7. Bibcode:1937PNAS...23..133P. doi:10.1073/pnas.23.3.133. PMC 1076884. PMID 16588136.
- Furukawa T, Mukherjee S, Bao ZZ, Morrow EM, Cepko CL (2000). "Rax, Hes1, and Notch1 promote the formation of Muller glia by postnatal retinal progenitor cells". Neuron 26: 383–394. doi:10.1016/S0896-6273(00)81171-X.
- Scheer N, Groth A, Hans S, Campos-Ortega JA (April 2001). "An instructive function for Notch in promoting gliogenesis in the zebrafish retina". Development 128 (7): 1099–107. PMID 11245575.
- Redmond L. et al. (2000). "Nuclear Notch1 signaling and the regulation of dendritic development". Nat. Neurosci 3: 30–40. doi:10.1038/71104.
- Costa R.M., Honjo T., Silva A.J. "Learning and memory deficits in Notch mutant mice. (2003)". Curr. Biol. 13: 1348–1354. doi:10.1016/S0960-9822(03)00492-5.
- Bolós, V. et al. (2007). "Notch Signaling in Development and Cancer". Endocrine Reviews 28 (3): 339–363. doi:10.1210/er.2006-0046. PMID 17409286.
- Zhong W, Jiang MM, Weinmaster G, Jan LY, Jan YN (May 1997). "Differential expression of mammalian Numb, Numblike and Notch1 suggests distinct roles during mouse cortical neurogenesis". Development 124 (10): 1887–97. PMID 9169836.
- Li H. S. et al. (December 2003). "Inactivation of Numb and Numb like in embryonic dorsal forebrain impairs neurogenesis and disrupts cortical morphogenesis. 2003;". Neuron 40 (6): 1105–1118. doi:10.1016/S0896-6273(03)00755-4. PMID 14687546.
- Androutsellis-Theotokis A, Leker RR, Soldner F et al. (August 2006). "Notch signalling regulates stem cell numbers in vitro and in vivo". Nature 442 (7104): 823–6. Bibcode:2006Natur.442..823A. doi:10.1038/nature04940. PMID 16799564.
- Rusanescu G, Mao J (Oct 2014). "Notch3 is necessary for neuronal differentiation and maturation in the adult spinal cord". J Cell Mol Med 18 (10): 2003–16. doi:10.1111/jcmm.12362. PMID 25164209.
- Klein, A.L.et. al Murine numb regulates granule cellmaturation in the cerebellum. (2004) Dev. Biol. 266, 161–177 doi:10.1016/j.ydbio.2003.10.017
- Huang E.J. et al. "Targeted deletion of numb and numb-like in sensory neurons reveals their essential functions in axon arborization. (2005)". Genes Dev. 19: 138–151. doi:10.1101/gad.1246005.
- Presente A, Andres A, Nye JS (October 2001). "Requirement of Notch in adulthood for neurological function and longevity". NeuroReport 12 (15): 3321–5. doi:10.1097/00001756-200110290-00035. PMID 11711879.
- Saura C.A. et al. "Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. (2004)". Neuron 42: 23–36. doi:10.1016/S0896-6273(04)00182-5.
- Kume T (2012). "Ligand-dependent Notch signaling in vascular formation". Adv. Exp. Med. Biol. 727: 210–22. doi:10.1007/978-1-4614-0899-4_16. PMID 22399350.
- Niessen Kyle, Karsan Aly (May 2008). "Notch Signaling in Cardiac Development (2008)". Circulation Research 2008 (102): 1169–1181. doi:10.1161/CIRCRESAHA.108.174318. PMID 18497317.
- Rutenberg JB, Fischer A, Jia H, Gessler M, Zhong TP, Mercola M (November 2006). "Developmental patterning of the cardiac atrioventricular canal by Notch and Hairy-related transcription factors". Development 133 (21): 4381–90. doi:10.1242/dev.02607. PMID 17021042.
- Kokubo H, Tomita-Miyagawa S, Hamada Y, Saga Y (February 2007). "Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2". Development 134 (4): 747–55. doi:10.1242/dev.02777. PMID 17259303.
- Timmerman LA et al. (2004). "Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation". Genes Dev 18: 99–115. doi:10.1101/gad.276304.
- Crosby CV et al. (April 2005). "VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. (2005)". Blood 105 (7): 2771–2776. doi:10.1182/blood-2004-06-2244. PMID 15604224.
- Noseda M et al. "Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. (2004)". Circ Res. 94: 910–917. doi:10.1161/01.RES.0000124300.76171.C9.
- Timmerman LA et al. (2004). "Notch promotes epithelialmesenchymaltransition during cardiac development and oncogenic transformation". Genes Dev 18: 99–115. doi:10.1101/gad.276304.
- Rones MS, McLaughlin KA, Raffin M, Mercola M (September 2000). "Serrate and Notch specify cell fates in the heart field by suppressing cardiomyogenesis". Development 127 (17): 3865–76. PMID 10934030.
- Nemir M, Croquelois A et al. (2006). "Induction of cardiogenesis in embryonic stem cells via downregulation of Notch1 signaling". Circ Res 98: 1471–1478. doi:10.1161/01.RES.0000226497.52052.2a.
- Grego-Bessa J, et al Notch signaling is essential for ventricular chamber development. DevCell. 2007;12:415– 429 doi: 10.1016/j.devcel.2006.12.011
- Wang J et al. (2005). "Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart". Dev Biol 286: 299–310. doi:10.1016/j.ydbio.2005.07.035.
- Xin M et al. (2007). "Essential roles of the bHLH transcription factor Hrt2 in repression of atrial gene expression and maintenance of postnatal cardiac function". Proc Natl Acad Sci U S A 104: 7975–7980. Bibcode:2007PNAS..104.7975X. doi:10.1073/pnas.0702447104.
- High FA et al. (2007). "An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation". J Clin Invest 117: 353–363. doi:10.1172/JCI30070.
- Hellstrom M et al. (2007). "Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis". Nature 445: 776–80. doi:10.1038/nature05571;.
- Leslie JD, et al., "Endothelial signalling by the Notch ligand Delta?like 4 restricts angiogenesis" Development 2007; 134:839?44. doi: 10.1242/dev.003244
- Lobov IB et al. (2007). "Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting". Proc Natl Acad Sci USA 104 (9): 3219–24. Bibcode:2007PNAS..104.3219L. doi:10.1073/pnas.0611206104. PMC 1805530. PMID 17296940.
- Siekmann AF, Lawson ND. "Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries" Nature 2007; 445:781?4. doi:10.1038/nature05577;
- Arndt F. Siekmann Nathan D. Lawson, Notch Signalling and the Regulation of Angiogenesis doi:10.4161/cam.1.2.4488
- Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 2001; 49:568?81. doi: 10.1016/S0008-6363(00)00268-6
- Williams CK,et al. Up?regulation of the Notch ligand Delta?like 4 inhibits VEGF?induced endothelial cell function" Blood 2006; 107:931?9. doi: 10.1182/blood-2005-03-1000
- Lawson ND, Scheer N, Pham VN et al. (October 2001). "Notch signaling is required for arterial-venous differentiation during embryonic vascular development". Development 128 (19): 3675–83. PMID 11585794.
- Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, Lendahl U, Edlund H. Notch signaling controls pancreatic cell differentiation. (1999)" Nature 400:877–881 doi: 10.1038/23716
- Lammert E, Brown J, Melton DA. Notch gene expression during pancreatic organogenesis. (2000). Mech Dev 94:199–203 doi:10.1016/S0925-4773(00)00317-8
- Field HA, Dong PD, Beis D, Stainier DY. Formation of the digestive system in zebrafish. II. Pancreas morphogenesis. (2003)" Dev Biol 261:197–208 doi:10.1016/S0012-1606(03)00308-7
- Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, Guillemot F, Serup P, Madsen OD. Control of endodermal endocrine development by Hes-1. (2000)" Nat Genet 24:36–44 doi:10.1038/71657
- Jensen J. Gene regulatory factors in pancreatic development. (2004). Dev Dyn 229:176–200 doi: 10.1002/dvdy.10460
- Norgaard GA, Jensen JN, Jensen J. FGF10 signaling maintains the pancreatic progenitor cell state revealing a novel role of Notch in organ development. (2003)" Dev Biol 264:323–338 doi:10.1016/j.ydbio.2003.08.013
- Crosnier C, Vargesson N, Gschmeissner S, Ariza-McNaughton L, Morrison A, Lewis J. Delta-Notch signalling controls commitment to a secretory fate in the zebrafish intestine. (2005)" Development 132:1093–1104 doi: 10.1242/dev.01644
- Yamada T, Yamazaki H, Yamane T, Yoshino M, Okuyama H, Tsuneto M, Kurino T, Hayashi S, Sakano S. et al. "Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. (2003)". Blood 101: 2227–2234. doi:10.1182/blood-2002-06-1740.
- Watanabe N et al. ", Suppression of differentiation and proliferation of early chondrogenic cells by Notch. (2003)". J Bone Miner Metab 21: 344–352. doi:10.1007/s00774-003-0428-4.
- Nobta M, Tsukazaki T, Shibata Y, Xin C, Moriishi T, Sakano S, Shindo H, Yamaguchi A (April 2005). "Critical regulation of bone morphogenetic protein-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 signaling. (2005)". J Biol Chem 280 (16): 15842–15848. doi:10.1074/jbc.M412891200. PMID 15695512.
- Purow (2012). "NOTCH INHIBITION AS A PROMISING NEW APPROACH TO CANCER THERAPY". Adv Exp Med Biol 727: 305–19. doi:10.1007/978-1-4614-0899-4_23. PMC 3361718. PMID 22399357.
- Espinoza; Miele (2013). "Notch inhibitors for cancer treatment.". Pharmacol Ther 139 (2): 95–110. doi:10.1016/j.pharmthera.2013.02.003. PMID 23458608.
- "Notch inhibitors could help overcome therapy resistance in ER-positive breast cancer". 2015.